Robert Luther Huffines

Insider Reports History

Location: Acton, MA
Owner filing signature: /s/ Patricia K. Dolan, attorney-in-fact
Transaction evidence: Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert Luther Huffines

Form 4 holding Director

Walgreens Boots Alliance, Inc.

Security class: Phantom Stock Units
Shares / value: 46,813
Estimated value: $556,607
Report date: 13 Aug 2025
Price: $11.89
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

INSULET CORP

Security class: Common Stock
Shares / value: 2,298
Estimated value: $482,212
Report date: 20 May 2026
Price: $209.84
Ownership: Direct

Form 4 holding Director

BECTON DICKINSON & CO

Security class: Common Stock
Shares / value: 1,279
Estimated value: $248,215
Report date: 27 Jan 2026
Price: $194.07
Ownership: Direct

Form 4 holding Director

BECTON DICKINSON & CO

Security class: Rights to Common Stock Under BD Deferred Compensation Plan
Shares / value: 404
Estimated value: $20,191
Report date: 08 May 2026
Price: $201.91
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

Eikon Therapeutics, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 25,873
Estimated value
Report date: 02 Mar 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

Solid Biosciences Inc.

Security class: Director Stock Option (Right to Buy)
Shares / value: 9,650
Estimated value
Report date: 13 Dec 2022
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

BECTON DICKINSON & CO

Security class: No securities are beneficially owned
Shares / value: 0
Estimated value
Report date: 01 Dec 2025
Price
Ownership: Direct

Insider Reports Filed by Robert Luther Huffines

4 PODD

INSULET CORP

Report period: 20 May 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 21 May 2026, 16:34
Role: Director
Next action: Open filing details

4 BDX

BECTON DICKINSON & CO

Report period: 08 May 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 08 May 2026, 17:26
Role: Director
Next action: Open filing details

4 PODD

INSULET CORP

Report period: 31 Mar 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Apr 2026, 16:08
Role: Director
Next action: Open filing details

4 EIKN

Eikon Therapeutics, Inc.

Report period: 02 Mar 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Mar 2026, 17:02
Role: Director
Next action: Open filing details

4 BDX

BECTON DICKINSON & CO

Report period: 04 Feb 2026
Transactions: 1
Transaction value: +$20,191
Accepted by SEC: 05 Feb 2026, 12:24
Role: Director
Next action: Open filing details

3 EIKN

Eikon Therapeutics, Inc.

Report period: 04 Feb 2026
Transactions: 0
Transaction value: $0
Accepted by SEC: 04 Feb 2026, 21:32
Role: Director
Next action: Open filing details

4 BDX

BECTON DICKINSON & CO

Report period: 27 Jan 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 29 Jan 2026, 09:50
Role: Director
Next action: Open filing details

4 PODD

INSULET CORP

Report period: 31 Dec 2025
Transactions: 1
Transaction value: +$14,443
Accepted by SEC: 06 Jan 2026, 16:38
Role: Director
Next action: Open filing details

4 BDX

BECTON DICKINSON & CO

Report period: 01 Dec 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Dec 2025, 14:55
Role: Director
Next action: Open filing details

3 BDX

BECTON DICKINSON & CO

Report period: 01 Dec 2025
Transactions: 0
Transaction value: $0
Accepted by SEC: 02 Dec 2025, 14:39
Role: Director
Next action: Open filing details

4 PODD

INSULET CORP

Report period: 31 Oct 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Nov 2025, 17:36
Role: Director
Next action: Open filing details

3 PODD

INSULET CORP

Report period: 31 Oct 2025
Transactions: 0
Transaction value: $0
Accepted by SEC: 03 Nov 2025, 17:33
Role: Director
Next action: Open filing details

4 WBA

Walgreens Boots Alliance, Inc.

Report period: 13 Aug 2025
Transactions: 1
Transaction value: +$200,000
Accepted by SEC: 15 Aug 2025, 18:18
Role: Director
Next action: Open filing details

4 WBA

Walgreens Boots Alliance, Inc.

Report period: 09 Jul 2025
Transactions: 1
Transaction value: +$25,000
Accepted by SEC: 11 Jul 2025, 17:21
Role: Director
Next action: Open filing details

4 WBA

Walgreens Boots Alliance, Inc.

Report period: 16 Apr 2025
Transactions: 1
Transaction value: +$25,000
Accepted by SEC: 18 Apr 2025, 17:56
Role: Director
Next action: Open filing details

4 WBA

Walgreens Boots Alliance, Inc.

Report period: 30 Jan 2025
Transactions: 1
Transaction value: +$25,000
Accepted by SEC: 03 Feb 2025, 19:29
Role: Director
Next action: Open filing details

4 WBA

Walgreens Boots Alliance, Inc.

Report period: 01 Nov 2024
Transactions: 1
Transaction value: +$150,000
Accepted by SEC: 05 Nov 2024, 20:49
Role: Director
Next action: Open filing details

4 WBA

Walgreens Boots Alliance, Inc.

Report period: 24 Oct 2024
Transactions: 1
Transaction value: +$25,000
Accepted by SEC: 28 Oct 2024, 17:02
Role: Director
Next action: Open filing details

4 WBA

Walgreens Boots Alliance, Inc.

Report period: 10 Jul 2024
Transactions: 1
Transaction value: +$25,000
Accepted by SEC: 12 Jul 2024, 16:57
Role: Director
Next action: Open filing details

4 WBA

Walgreens Boots Alliance, Inc.

Report period: 25 Apr 2024
Transactions: 1
Transaction value: +$25,000
Accepted by SEC: 29 Apr 2024, 18:02
Role: Director
Next action: Open filing details

4 WBA

Walgreens Boots Alliance, Inc.

Report period: 25 Jan 2024
Transactions: 1
Transaction value: +$9,890
Accepted by SEC: 29 Jan 2024, 18:11
Role: Director
Next action: Open filing details

3 WBA

Walgreens Boots Alliance, Inc.

Report period: 25 Jan 2024
Transactions: 0
Transaction value: $0
Accepted by SEC: 29 Jan 2024, 18:08
Role: Director
Next action: Open filing details

4 SLDB

Solid Biosciences Inc.

Report period: 13 Dec 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 15 Dec 2022, 17:13
Role: Director
Next action: Open filing details

4 SLDB

Solid Biosciences Inc.

Report period: 07 Jun 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 09 Jun 2022, 17:00
Role: Director
Next action: Open filing details

4 SLDB

Solid Biosciences Inc.

Report period: 16 Jun 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 21 Jun 2021, 16:00
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .